Author(s): Jean-Pierre Louboutin, David S. Strayer
Post# of 144900
![](/assets/46931549/no_avatar_available_thumb.jpg)
Journal Name: CNS & Neurological Disorders - Drug Targets
(Formerly Current Drug Targets - CNS & Neurological Disorders)
Volume 12 , Issue 6 , 2013
I have seen CCR 5 in so many early research papers on as many indications as there are now in Leronlimab. All offered the same conclusion; CCR5 may help modulate ...."
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)